<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bandaram Pharma Packtech Ltd has submitted an annual disclosure to BSE confirming that the company does not fall under the 'Large Corporate' (LC) category as defined by SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. This circular relates to fund-raising through debt securities and associated disclosure obligations for large entities. The disclosure was filed on April 30, 2025, and signed by B. Deepak Reddy, Chairman and Managing Director. This is a routine compliance submission indicating the company does not meet the thresholds (typically based on borrowings) that would classify it as a Large Corporate.
This is a routine regulatory filing with no material impact on shareholders or the stock price. It simply confirms that the company is not large enough to be subject to additional SEBI disclosure requirements related to debt securities, suggesting its borrowing levels remain below the Large Corporate threshold.